Primary Device ID | 00365649850035 |
NIH Device Record Key | deb3c664-29a9-4a16-8813-38ea2ffe3bbb |
Commercial Distribution Status | In Commercial Distribution |
Brand Name | Solesta® |
Version Model Number | 1085003 |
Company DUNS | 793108036 |
Company Name | SALIX PHARMACEUTICALS, LTD. |
Device Count | 1 |
DM Exempt | false |
Pre-market Exempt | false |
MRI Safety Status | Labeling does not contain MRI Safety Information |
Human Cell/Tissue Product | false |
Device Kit | false |
Device Combination Product | false |
Single Use | true |
Lot Batch | true |
Serial Number | false |
Manufacturing Date | false |
Expiration Date | true |
Donation Id Number | false |
Contains Natural Rubber Latex | false |
Labeled No Natural Rubber Latex | false |
RX Perscription | true |
OTC Over-The-Counter | false |
Phone | 8005080024 |
salix@medcomsol.com | |
Phone | 8005080024 |
salix@medcomsol.com | |
Phone | 8005080024 |
salix@medcomsol.com | |
Phone | 8005080024 |
salix@medcomsol.com | |
Phone | 8005080024 |
salix@medcomsol.com | |
Phone | 8005080024 |
salix@medcomsol.com | |
Phone | 8005080024 |
salix@medcomsol.com | |
Phone | 8005080024 |
salix@medcomsol.com | |
Phone | 8005080024 |
salix@medcomsol.com | |
Phone | 8005080024 |
salix@medcomsol.com | |
Phone | 8005080024 |
salix@medcomsol.com | |
Phone | 8005080024 |
salix@medcomsol.com | |
Phone | 8005080024 |
salix@medcomsol.com | |
Phone | 8005080024 |
salix@medcomsol.com |
Device Issuing Agency | Device ID |
---|---|
GS1 | 00365649850035 [Primary] |
GS1 | 10365649850032 [Package] Package: Transport box [32 Units] In Commercial Distribution |
LNM | Agent, Bulking, Injectable For Gastro-Urology Use |
Steralize Prior To Use | false |
Device Is Sterile | true |
Public Version Status | Update |
Device Record Status | Published |
Public Version Number | 3 |
Public Version Date | 2018-07-06 |
Device Publish Date | 2014-10-31 |
00365649850035 - Solesta® | 2018-07-06SOLESTA® is indicated for the treatment of fecal incontinence in patients 18 years and older who have failed conservative therapy (eg. diet, fiber therapy, anti-motility medications). |
00365649850035 - Solesta® | 2018-07-06 SOLESTA® is indicated for the treatment of fecal incontinence in patients 18 years and older who have failed conservative thera |
00365649922039 - Deflux® | 2018-07-06 Deflux® is a bulking agent indicated for treatment of children with vesicoureteral reflux (VUR) grades II-IV. |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
SOLESTA 90465463 not registered Live/Pending |
Galderma Holding S.A. 2021-01-14 |
SOLESTA 88090466 not registered Live/Pending |
Néstlé Skin Health S.A. 2018-08-23 |
SOLESTA 78853445 3352167 Dead/Cancelled |
NESTLÃ SKIN HEALTH S.A. 2006-04-04 |